EBS News and Press, Emergent Biosolutions Inc. From 11/21/19

GAITHERSBURG, Md., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today outlined its growth strategy over the next five years and announced its 2024 financial and operational goals during the company’s Analyst and Investor Day held in New York City. Emergent...

GAITHERSBURG, Md., Nov. 18, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will be hosting an analyst and investor day on November 21, 2019 from 8:00 AM EST to 2:00 PM EST in New York City. This event is designed for sellside research analysts and institutional investors an...

Noteworthy events during the week of November 17 - 23 for healthcare investors. More news on: Resverlogix Corp., Surface Oncology, Inc., Humanigen, Inc., Healthcare stocks news, , Read more ...

Emergent BioSolutions Inc. (EBS) Q3 2019 Results Earnings Conference Call November 06, 2019, 05:00 PM ET Company Participants Bob Burrows - VP, IR Bob Kramer - President and CEO Rich Lindahl - CFO Doug White - SVP, Devices Business Unit Head Adam Havey - EVP, Operations Co...

AAOI , AEL , AIMT , ALB , ANGI , ANSS , ASRT , ATO , ATSG , AXGN , BAND , BIDU , BL , BNFT , BRKS , CECO , CNDT , COLL , CTL , CVNA , CXW , DAR , DCP , DVAX , DXCM , DXPE , EBS , ECPG , EGAN , ENS , EOG , EQH , ERI , ET , EVRG , EXPE , FG , FISV , FIT ...

Below are the five companies in the Biotechnology industry with the lowest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry. Actinium Pharmaceuticals Inc. ranks lowest with sales per share of $0.00. Following is Pfenex Inc. w...

GAITHERSBURG, Md., Oct. 21, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the company will host an analyst and investor day on November 21, 2019 in New York City. This event, which is designed for sellside research analysts and institutional investors,...

Below are the five companies in the Biotechnology industry with the highest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry. AbbVie Inc. ranks highest with sales per share of $18.55. Emergent BioSolutions Inc. is next with s...

The Committee for Medicinal Products for Human Use (CHMP) of the EMA grants Emergent BioSolutions' (NYSE: EBS ) chikungunya virus (CHIKV) virus-like particle (VLP) vaccine candidate, CHIKV VLP, PRIority MEdicines, or PRIME, designation. More news on: Emergent BioSolutions Inc., Healthcar...

GAITHERSBURG, Md., Oct. 10, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that the company’s chikungunya virus (CHIKV) virus-like particle (VLP) vaccine candidate, CHIKV VLP, was granted PRIority MEdicines, or PRIME, designation by the Committee for M...